Insider · CIK 0001579891
John W. Higuchi
Files at LPCN (Lipocine Inc.). First filing Apr 6, 2026, latest Oct 1, 2026.
In brief
John W. Higuchi files SEC Form 4 as director at LPCN (Lipocine Inc.). Since Apr 6, 2026, John W. Higuchi has reported 4 open-market buys worth $416k and 0 open-market sells worth $0, the latest filed on Oct 1, 2026.
A track record needs three past buys with six months of prices behind them; John W. Higuchi has 0, so none is measured yet.
The newest scored trade: bought $55k of LPCN on Sep 29, 2026, filed Oct 1, 2026, scored 38 (weak). In the last 12 months: 4 buys worth $416k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LPCN: Lipocine Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | LPCNbuy Lipocine Inc. | $55k 25,007 shares | +12% | +11% from low-81% from high | |
| 41Moderate | LPCNbuy Lipocine Inc. | $27k 12,561 shares | +6% | +8% from low-81% from high | |
| 61Notable | Lipocine Inc. | $81k 40,000 shares | +24% | +3% from low-82% from high | |
| 64Notable | Lipocine Inc. | $252k 123,000 shares | +301% | 0% from low-83% from high |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | LPCN Lipocine Inc. | POpen-market purchase Common stock | +9,037 | $2.15 | $19k | 225,395 | 12 d ago |
| Sep 30, 2026 | LPCN Lipocine Inc. | POpen-market purchase Common stock | +15,970 | $2.23 | $36k | 241,365 | 12 d ago |
| Sep 28, 2026 | LPCN Lipocine Inc. | POpen-market purchase Common stock | +12,561 | $2.16 | $27k | 216,358 | 13 d ago |
| Jun 3, 2026 | LPCN Lipocine Inc. | AGrant or award Common Stock (Right to Buy)derivative | +1,764 | $2.19 | $3,863 | 13,290 | Jun 4, 2026 |
| Apr 7, 2026 | LPCN Lipocine Inc. | POpen-market purchase Common stock | +40,000 | $2.03 | $81k | 203,797 | Apr 7, 2026 |
| Apr 6, 2026 | LPCN Lipocine Inc. | POpen-market purchase Common stock | +123,000 | $2.05 | $252k | 163,797 | Apr 6, 2026 |
| Jun 4, 2025 | LPCN Lipocine Inc. | AGrant or award Common Stock (Right to Buy)derivative | +1,764 | $3.20 | $5,645 | 11,526 | Jun 5, 2025 |
Questions about John W. Higuchi
Answered from the filings on this page, as of the latest one.
Is John W. Higuchi buying or selling?
In the last 12 months John W. Higuchi reported 4 open-market buys worth $416k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $55k of LPCN on Sep 29, 2026. Grants, option exercises and tax withholding are not counted.
How did John W. Higuchi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John W. Higuchi has 0.
Where does John W. Higuchi file Form 4?
John W. Higuchi has filed Form 4 at LPCN (Lipocine Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.